1. Home
  2. DAKT vs ORIC Comparison

DAKT vs ORIC Comparison

Compare DAKT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.59

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.44

Market Cap

783.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
ORIC
Founded
1968
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
783.0M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
DAKT
ORIC
Price
$20.59
$8.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
$26.00
$19.73
AVG Volume (30 Days)
618.1K
1.4M
Earning Date
12-10-2025
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
N/A
Revenue This Year
$13.76
N/A
Revenue Next Year
$7.35
N/A
P/E Ratio
$141.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$3.90
52 Week High
$24.38
$14.93

Technical Indicators

Market Signals
Indicator
DAKT
ORIC
Relative Strength Index (RSI) 63.28 39.26
Support Level $19.42 $7.84
Resistance Level $20.75 $8.92
Average True Range (ATR) 0.65 0.38
MACD 0.19 0.14
Stochastic Oscillator 92.63 67.28

Price Performance

Historical Comparison
DAKT
ORIC

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: